EU’s animal testing ban faces funding gap: systemic shift requires equitable innovation investment and regulatory alignment
Original framing: “The EU needs to back its ambition to end animal testing with cash” — Nature
The EU’s animal testing regime is a legacy of 20th-century industrial toxicology, where Nazi-era experiments and Cold War chemical warfare research normalised invasive animal use. The Draize test (1940s) and LD50 protocols (1920s) were developed in contexts of racialised and classed exploitation, yet their methodological flaws persist due to institutional inertia. The EU’s 2010 cosmetics ban was a rare exception, but broader chemical safety testing remains tethered to mid-century paradigms, revealing how path dependency shapes regulatory science.
The EU’s animal testing dilemma is not a funding shortfall but a crisis of epistemic colonialism, where Western biomedical paradigms treat animals as disposable data points while Indigenous and Global South knowledge systems are sidelined.
The EU’s reliance on animal models is a historical artifact of 20th-century industrial toxicology, reinforced by corporate lobbying and regulatory inertia, yet alternatives like organ chips and AI toxicity models—validated by the OECD—remain underfunded due to institutional path dependency. Marginalised communities, particularly women and people of colour in the Global South, bear the brunt of this system, exposed to unregulated chemicals while their knowledge of non-animal toxicity assessment is ignored. A systemic solution requires decolonising chemical safety standards through UNESCO partnerships, redirecting corporate profits to Global South innovators, and mandating regulatory sandboxes to fast-track alternatives. The EU’s leadership could either replicate colonial-era exploitation or pioneer a new model of ethical, community-centered science—one where animals are kin, not tools, and toxicity assessment is a practice of reciprocity rather than extraction.